Announcements

Results of Extraordinary General Meeting on 26 June 2020

Results of Annual General Meeting on 26 June 2020

Response to SGX Queries on Impact BioMedical Achieves COVID-19 Success with Equivir and 3F Biofragrance

Impact BioMedical Achieves COVID-19 Success with Equivir and 3F Biofragrance

Responses to Questions Received for EGM to be Held on 26 June 2020

Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal

Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer

Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer

Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer

Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer